(F12.3) Mental and behavioural disorders due to use of cannabinoids withdrawal state

More details coming soon

Icon
309 218 in individuals diagnosis mental and behavioural disorders due to use of cannabinoids withdrawal state confirmed
Icon
1 830 deaths with diagnosis mental and behavioural disorders due to use of cannabinoids withdrawal state
Icon
1% mortality rate associated with the disease mental and behavioural disorders due to use of cannabinoids withdrawal state

Diagnosis mental and behavioural disorders due to use of cannabinoids withdrawal state is diagnosed Men are 63.84% more likely than Women

253 307

Men receive the diagnosis mental and behavioural disorders due to use of cannabinoids withdrawal state

1 830 (0.7 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
55 911

Women receive the diagnosis mental and behavioural disorders due to use of cannabinoids withdrawal state

0 (less than 0.1%)

Died from this diagnosis.

Risk Group for the Disease mental and behavioural disorders due to use of cannabinoids withdrawal state - Men and Women aged 15-19

Icon
In Men diagnosis is most often set at age 10-84
Icon
Less common in men the disease occurs at Age 0-9, 85-95+Less common in women the disease occurs at Age 0-9, 70-74, 80-95+
Icon
In Women diagnosis is most often set at age 10-69, 75-79

Disease Features mental and behavioural disorders due to use of cannabinoids withdrawal state

Icon
Absence or low individual and public risk
Icon

Mental and behavioural disorders due to use of cannabinoids withdrawal state - what does this mean

Mental and behavioural disorders due to use of cannabinoids withdrawal state typically occur when someone has been using cannabis for an extended period of time and then suddenly stops. symptoms of withdrawal may include anxiety, irritability, insomnia, decreased appetite, restlessness, and depression.

What happens during the disease - mental and behavioural disorders due to use of cannabinoids withdrawal state

Cannabis withdrawal syndrome is a collection of symptoms that occur when an individual stops using cannabis after regular, prolonged use. the symptoms are caused by the body’s adaptation to the presence of cannabinoids in the system, and can include anxiety, irritability, sleep disturbances, decreased appetite, increased cravings for cannabis, and other mental and behavioural abnormalities.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Physical examination
  • Psychological evaluation
  • Laboratory tests
  • Urine drug screen
  • Blood tests
  • Imaging tests
  • Neuropsychological tests
  • Sleep studies
  • Genetic testing

Treatment and Medical Assistance

Main Goal: Treat the mental and behavioural disorders due to use of cannabinoids withdrawal state.
  • Identify risk factors for developing cannabinoid use disorder
  • Develop a plan for managing withdrawal symptoms
  • Provide psychoeducation about the disorder and its treatment
  • Provide cognitive-behavioral therapy
  • Encourage healthy lifestyle habits
  • Provide support for relapse prevention
  • Monitor for signs of relapse
  • Refer to other professionals, as needed
Icon
37 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Mental and behavioural disorders due to use of cannabinoids withdrawal state - Prevention

The best way to prevent mental and behavioural disorders due to use of cannabinoids withdrawal state is to avoid using cannabinoids in the first place, and to seek help if one is already using them. treatment options such as cognitive behavioural therapy and medication can be used to reduce the risk of these disorders. additionally, it is important to engage in healthy lifestyle practices such as regular exercise, balanced nutrition, and adequate sleep.